Navigation Links
Varian Medical Systems Has Received CE Mark for Proton Therapy System
Date:2/19/2009

PALO ALTO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received CE mark for the Varian Proton Therapy System, which is designed to help doctors to improve treatments and outcomes in many cancer cases. With proton therapy, doctors can use higher doses of radiation to control and manage tumors while significantly reducing damage to healthy tissue and vital organs.

"CE mark is an important milestone in Varian's initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities," said Lester Boeh, vice president of emerging businesses for the company. "This is a clear demonstration of our ongoing commitment to provide the cancer treatment community and its patients with a clinically practical and commercially viable proton therapy system that meets accepted safety standards for medical equipment."

The CE mark makes it possible for cancer treatment centers to begin ordering, installing, and using the Varian Proton Therapy System in regions where CE mark is required without having to obtain a site-specific clearance to use this important technology. "Varian is actively marketing the Varian Proton Therapy System, and institutions from all parts of the world are pursuing this promising technology for cancer patients in their regions," Boeh said.

Through research and development and the acquisition of ACCEL in Germany during 2007, Varian has developed a comprehensive proton therapy system that utilizes the company's technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.
4. Fertility Drugs Do Not Increase Ovarian Cancer Risk
5. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
6. Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009
8. Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbotts Architect(R) Analyzers
9. Gene Variant Raises Risk for Brain Cancer at Young Age
10. Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery
11. A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... President ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ ... Future study (MTF) -- the largest survey on teen ... graders -- underscores that teens, intentional abuse of prescription ... cause for concern, with an alarming number of young ... ,, Teen Abuse of Medication Continues ...
(Date:12/14/2009)... Dec. 14 The Hemophilia Federation of ... labor issues involving the Teamsters Local 929 and ... The national blood system depends on skilled workers ... blood is distilled into products such as clotting ... Willebrand disease. ,, The Division of Blood ...
(Date:12/14/2009)... treated, hadn,t spread, study finds , , MONDAY, Dec. 14 ... of death in male colon cancer survivors, researchers report. ... 668 men who,d been treated for stage I, stage ... spread (nonmetastatic cancer). Every two years, the men were ... and disease diagnoses, as well as their physical activity. ...
(Date:12/14/2009)... may also offer some protection, study finds, , , MONDAY, ... people who can,t start their morning without a cup ... decrease the risk of developing type 2 diabetes. ... also found the more coffee you drink, the lower ... associated with a 7 percent reduction in the risk ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... Obese and overweight men who are diagnosed with prostate cancer ... actually have a more aggressive// case of the disease than ... by a Duke University Medical Center researcher. ,The ... obese and overweight men to receive inadequate or inappropriate treatment ...
... LEXINGTON, Ky. − When studying a new blood thinner, one ... a slight increase in minor bleeding—nose bleeds and bruising,// an ... the leading cause of heart attack and stroke. While potentially ... bleeding in some patients, requiring frequent monitoring of blood levels. ...
... interventions on their children, hoping life would become that much bearable// ... debate in the US. ,Ashley of Seattle was born ... only three months old. , She is sensate, she ... to enjoy music. But she can barely move and will never ...
... White House Press Secretary Tony Snow has bad news. His ... sadly resurfaced//. ,Snow was treated with chemotherapy ... prevent satellite growths of tumors that could be metastatic. Yet ... pelvic area, doctors discovered additional tumors in his liver. ...
... to control high blood pressure and new drugs that ... researchers have designed two promising new cardiovascular treatment approaches, ... form to lower high blood pressure and a therapeutic ... function. ,In the process, they have ...
... Fractures are a common injury among children, yet the ... special musculoskeletal problems// of children is decreasing nationwide. The ... in adults. Specialized knowledge and training is needed to ... orthopedic surgeons at New York’s Hospital for Special Surgery ...
Other Medicine News:Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Debate in US: Who Should Decide for Disabled People? 2Health News:White House Press Secretary to Battle Second Round of Colon Cancer 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3
(Date:12/14/2009)... Dec. 14 According to Millennium ... medical technology market intelligence, Japan,s complex regulatory ... created a significant lag in peripheral vascular ... to other developed nations. MRG,s new ... 2010 report finds, however, that recent ...
(Date:12/14/2009)... Manchester Pharmaceuticals, Inc.(TM) announced today the ... On October 22, 2009, the US Food and ... for patients suffering from gallstones in whom surgery ... or advanced age. ,, Chenodal prescriptions have started ... Health Resources ("Centric"), a specialty pharmacy company. ...
(Date:12/14/2009)... N.C., Dec. 14 Oxygen Biotherapeutics, Inc. (OTC ... company,s board of directors with the addition of Lt. ... Blanck is chairman of Martin, Blanck & Associates, a ... Virginia. With his addition, the company board now has ... in 1968 as a medical officer and battalion surgeon ...
Breaking Medicine Technology:Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3Manchester Announces Availability of Chenodal(TM) 2Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 1Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 2Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 3Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 4Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 5Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 6Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 7PDI Reports 2009 Third Quarter Financial Results 6023 1PDI Reports 2009 Third Quarter Financial Results 6023 2PDI Reports 2009 Third Quarter Financial Results 6023 3PDI Reports 2009 Third Quarter Financial Results 6023 4PDI Reports 2009 Third Quarter Financial Results 6023 5PDI Reports 2009 Third Quarter Financial Results 6023 6PDI Reports 2009 Third Quarter Financial Results 6023 7PDI Reports 2009 Third Quarter Financial Results 6023 8PDI Reports 2009 Third Quarter Financial Results 6023 9PDI Reports 2009 Third Quarter Financial Results 6023 10PDI Reports 2009 Third Quarter Financial Results 6023 11Complete Horse Genome Sequence Revealed 60783 1Complete Horse Genome Sequence Revealed 60783 2
... Israel, February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), ... that it has concluded a proof of concept,study ... its,proprietary technology. Eight healthy volunteers came for two ... The insulin suppositories showed rapid insulin absorption ...
... PDUFA Date for Cinryze for Acute HAE Indication is June ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... priority review for Cinryze C1 Inhibitor (human) as a treatment ... Biologics License Application (sBLA), submitted to the FDA on December ...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: